Automation In Solid And Liquid Dosage Pharmaceutical Manufacturing Market
Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Forecasts to 2032 – Global Analysis By Dosage Form (Solid Dosage Form Automation, Liquid Dosage Form Automation, and Semisolid Dosage Form Automation), Packaging Type, Technology, Application, End User and By Geography.
According to Stratistics MRC, the Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market is accounted for $7.0 billion in 2025 and is expected to reach $15.0 billion by 2032 growing at a CAGR of 11.5% during the forecast period. Automation in pharmaceutical manufacturing involves using control systems to operate equipment for producing solid (tablets, capsules) and liquid (syrups, injections) dosage forms with minimal human intervention. It encompasses processes like dispensing, mixing, granulation, compression, filling, and packaging. This enhances precision, efficiency, and compliance with stringent regulations. By ensuring consistent product quality, reducing contamination risks, and improving batch traceability, automation is vital for scaling up production and maintaining Good Manufacturing Practice (GMP).
According to Springer’s Therapeutic Innovation & Regulatory Science journal, artificial intelligence is transforming liquid dosage formulation by enabling data-driven optimization. AI improves efficiency in drug discovery, formulation, and manufacturing, reducing reliance on trial-and-error methods
Market Dynamics:
Driver:
Rising demand for production efficiency
The increasing focus on improving production efficiency is propelling automation adoption in solid and liquid dosage pharmaceutical manufacturing. Fueled by the growing need to minimize manual intervention, enhance precision, and optimize throughput, manufacturers are investing in advanced automated systems. Automation solutions streamline operations, reduce cycle times, and ensure consistent quality, particularly in complex dosage formulations. Moreover, the integration of robotics and AI-driven control systems enhances process reliability, ensuring compliance with regulatory standards and scalability in pharmaceutical output.
Restraint:
High initial capital investment
Despite its benefits, high upfront investment acts as a key barrier to widespread automation deployment in pharmaceutical dosage manufacturing. The integration of robotics, vision inspection, and digital monitoring technologies requires significant capital, particularly for small and mid-sized firms. Additionally, customization and validation costs further elevate financial burdens. Spurred by stringent compliance requirements and maintenance complexities, many firms delay automation adoption. Consequently, the return on investment period extends, limiting faster technological penetration across developing pharmaceutical production environments.
Opportunity:
Growth in personalized medicine packaging
The emergence of personalized medicine is unlocking lucrative automation opportunities in pharmaceutical manufacturing. As customized dosage forms and patient-specific therapies gain traction, automated packaging and dosing systems ensure precision and flexibility. Advanced robotics and adaptive control technologies enable batch-level customization and real-time adjustments. Driven by the demand for individual-centric drug delivery, automation helps reduce errors, enhance traceability, and streamline small-batch production. Consequently, pharmaceutical players are adopting digital automation to support the scalability of personalized and precision-based drug packaging processes.
Threat:
Supply chain disruptions impact automation
Global supply chain disruptions pose a substantial threat to automation-driven pharmaceutical manufacturing. Interruptions in semiconductor availability, equipment logistics, and component shortages hinder system integration and commissioning. Moreover, dependency on specialized vendors for automation components amplifies vulnerability during geopolitical tensions. Spurred by fluctuating material costs and delayed installations, production continuity risks rise. Hence, companies increasingly focus on regionalized sourcing strategies and resilient supplier networks to mitigate automation downtime and maintain operational reliability in dosage manufacturing lines.
Covid-19 Impact:
The COVID-19 pandemic accelerated automation adoption across solid and liquid dosage manufacturing due to heightened demand for uninterrupted production. Fueled by labor shortages and social distancing norms, companies turned to robotic handling and automated inspection systems. Additionally, remote monitoring and digital twin technologies supported predictive maintenance and quality control. However, initial lockdowns delayed equipment procurement and installation. Over time, the crisis reinforced the strategic necessity for automation, transforming production agility and reinforcing resilience across pharmaceutical manufacturing workflows.
The solid dosage form automation segment is expected to be the largest during the forecast period
The solid dosage form automation segment is expected to account for the largest market share during the forecast period, propelled by its extensive application in tablet compression, coating, and packaging operations. Manufacturers are emphasizing precision and repeatability in large-scale tablet production, driving automation uptake. Fueled by demand for consistency and compliance, automated systems enhance throughput and quality control. Additionally, the segment benefits from increasing investments in robotic dispensing, automated filling, and inspection units that reduce operational variability.
The primary packaging automation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the primary packaging automation segment is predicted to witness the highest growth rate, influenced by rising requirements for product safety and contamination prevention. Driven by stringent regulatory mandates, automated primary packaging systems enhance sealing precision and minimize human contact. Furthermore, the growing shift toward blister, sachet, and vial packaging for both solid and liquid dosage forms accelerates adoption. Integration of machine vision and AI ensures labeling accuracy and traceability, boosting this segment’s expansion trajectory.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by rapid pharmaceutical manufacturing expansion in China, India, and South Korea. Government incentives supporting industrial automation and investments in advanced production facilities bolster growth. Additionally, rising generics output and contract manufacturing activities enhance automation integration. The region’s growing pool of skilled engineers and cost-effective deployment environments further strengthen its leadership in automated solid and liquid dosage manufacturing adoption.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong digital transformation initiatives and early technology adoption among major pharmaceutical firms. The region’s established regulatory framework encourages process validation through automation. Additionally, increasing investments in smart factories and data-driven manufacturing enhance production agility. Fueled by a growing focus on personalized medicine and stringent FDA compliance, automation uptake continues to surge across U.S. and Canadian dosage production facilities.
Key players in the market
Some of the key players in Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, Bosch Packaging, Syntegon, Körber Pharma, Becton Dickinson, IMA Group, Marchesini, OPTIMA Packaging, Uhlmann Pac-Systeme, Omnicell, ARxIUM, Yuyama Co., Ltd., Mitsubishi Electric, Honeywell, GEA Group, Thermo Fisher, and Schneider Electric.
Key Developments:
In September 2025, Siemens and Merck extended their strategic partnership to accelerate digital transformation in pharmaceutical manufacturing. The collaboration aims to integrate Merck’s SaaS products with Siemens’ digital ecosystem, deploying AI tools for smarter, faster drug development using technology from Siemens’ July 2025 Dotmatics acquisition.
In October 2025, Rockwell Automation launched the ControlLogix 5590 Controller, a next-generation platform designed for advanced industrial and pharmaceutical automation, featuring integrated safety and multidiscipline control for streamlined manufacturing.
In May 2025, Syntegon premiered its SynTiso line for automated liquid pharmaceutical filling, developed in direct collaboration with two major pharmaceutical partners, to enhance automation and yield while reducing operator intervention.
Dosage Forms Covered:
• Solid Dosage Form Automation
• Liquid Dosage Form Automation
• Semisolid Dosage Form Automation
Packaging Types Covered:
• Primary Packaging Automation
• Secondary Packaging Automation
• Tertiary Packaging Automation
Technologies Covered:
• Robotics & Pick-and-Place Systems
• Vision Inspection Systems
• Labeling& Serialization Systems
• Conveyors & Automated Material Handling
• Blow-Fill-Seal (BFS) Technology
• Form-Fill-Seal (FFS) Systems
Applications Covered:
• Drug Discovery & Development
• Clinical Trial Material Manufacturing
• Commercial Production &Processing
• Quality Control & Regulatory Compliance
• Logistics & Inventory Management
End Users Covered:
• Pharmaceutical Manufacturing Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs/CMOs)
• Research and Academic Institutions
• Packaging & Equipment Manufacturers
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Dosage Form
5.1 Introduction
5.2 Solid Dosage Form Automation
5.2.1 Tablet Manufacturing
5.2.2 Capsule Filling & Sealing Systems
5.2.3 Granulation, Blending & Compression Control
5.3 Liquid Dosage Form Automation
5.3.1 Syrup & Suspension Production
5.3.2 Aseptic Filling & Sterilization Systems
5.3.3 Liquid Mixing & Homogenization
5.4 Semisolid Dosage Form Automation
5.4.1 Ointment & Cream Manufacturing
5.4.2 Gel & Paste Mixing Systems
5.4.3 Tube Filling & Sealing
6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Packaging Type
6.1 Introduction
6.2 Primary Packaging Automation
6.2.1 Blister Packaging Machines
6.2.2 Bottle Filling & Capping Systems
6.2.3 Strip Packaging Equipment
6.2.4 Vial and Ampoule Packaging
6.2.5 Sachet and Pouch Filling Systems
6.3 Secondary Packaging Automation
6.3.1 Cartoning& Case Packing Systems
6.3.2 Bundling, Wrapping, & Shrink Packaging
6.3.3 Serialization & Aggregation Systems
6.3.4 Palletizing, Depalletizing, &Labeling Robots
6.4 Tertiary Packaging Automation
6.4.1 Automated Guided Vehicles (AGVs) for Warehouse Handling
6.4.2 Bulk Handling and Shipping Container Systems
7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Technology
7.1 Introduction
7.2 Robotics & Pick-and-Place Systems
7.3 Vision Inspection Systems
7.4 Labeling& Serialization Systems
7.5 Conveyors & Automated Material Handling
7.6 Blow-Fill-Seal (BFS) Technology
7.7 Form-Fill-Seal (FFS) Systems
8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Application
8.1 Introduction
8.2 Drug Discovery & Development
8.3 Clinical Trial Material Manufacturing
8.4 Commercial Production &Processing
8.4.1 Active Pharmaceutical Ingredient (API) Manufacturing
8.4.2 Formulation and Compounding
8.5 Quality Control & Regulatory Compliance
8.6 Logistics & Inventory Management
9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By End User
9.1 Introduction
9.2 Pharmaceutical Manufacturing Companies
9.3 Biotechnology Companies
9.4 Contract Development & Manufacturing Organizations (CDMOs/CMOs)
9.5 Research and Academic Institutions
9.6 Packaging & Equipment Manufacturers
10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Siemens Healthineers
12.2 Rockwell Automation
12.3 Bosch Packaging Technology
12.4 Syntegon Technology
12.5 Körber Pharma
12.6 Becton Dickinson (BD)
12.7 IMA Group
12.8 Marchesini Group
12.9 OPTIMA Packaging Group
12.10 Uhlmann Pac-Systeme
12.11 Omnicell Inc.
12.12 ARxIUM
12.13 Yuyama Co., Ltd.
12.14 Mitsubishi Electric
12.15 Honeywell Process Solutions
12.16 GEA Group
12.17 Thermo Fisher Scientific
12.18 Schneider Electric
List of Tables
1 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Region (2024-2032) ($MN)
2 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Dosage Form (2024-2032) ($MN)
3 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Solid Dosage Form Automation (2024-2032) ($MN)
4 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tablet Manufacturing (2024-2032) ($MN)
5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Capsule Filling & Sealing Systems (2024-2032) ($MN)
6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Granulation, Blending & Compression Control (2024-2032) ($MN)
7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Dosage Form Automation (2024-2032) ($MN)
8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Syrup & Suspension Production (2024-2032) ($MN)
9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Aseptic Filling & Sterilization Systems (2024-2032) ($MN)
10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Mixing & Homogenization (2024-2032) ($MN)
11 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Semisolid Dosage Form Automation (2024-2032) ($MN)
12 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Ointment & Cream Manufacturing (2024-2032) ($MN)
13 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Gel & Paste Mixing Systems (2024-2032) ($MN)
14 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tube Filling & Sealing (2024-2032) ($MN)
15 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging Type (2024-2032) ($MN)
16 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Primary Packaging Automation (2024-2032) ($MN)
17 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blister Packaging Machines (2024-2032) ($MN)
18 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bottle Filling & Capping Systems (2024-2032) ($MN)
19 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Strip Packaging Equipment (2024-2032) ($MN)
20 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vial and Ampoule Packaging (2024-2032) ($MN)
21 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Sachet and Pouch Filling Systems (2024-2032) ($MN)
22 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Secondary Packaging Automation (2024-2032) ($MN)
23 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Cartoning& Case Packing Systems (2024-2032) ($MN)
24 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bundling, Wrapping, & Shrink Packaging (2024-2032) ($MN)
25 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Serialization & Aggregation Systems (2024-2032) ($MN)
26 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Palletizing, Depalletizing, &Labeling Robots (2024-2032) ($MN)
27 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tertiary Packaging Automation (2024-2032) ($MN)
28 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Automated Guided Vehicles (AGVs) for Warehouse Handling (2024-2032) ($MN)
29 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bulk Handling and Shipping Container Systems (2024-2032) ($MN)
30 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Technology (2024-2032) ($MN)
31 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Robotics & Pick-and-Place Systems (2024-2032) ($MN)
32 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vision Inspection Systems (2024-2032) ($MN)
33 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Labeling& Serialization Systems (2024-2032) ($MN)
34 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Conveyors & Automated Material Handling (2024-2032) ($MN)
35 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blow-Fill-Seal (BFS) Technology (2024-2032) ($MN)
36 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Form-Fill-Seal (FFS) Systems (2024-2032) ($MN)
37 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Application (2024-2032) ($MN)
38 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
39 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Clinical Trial Material Manufacturing (2024-2032) ($MN)
40 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Commercial Production &Processing (2024-2032) ($MN)
41 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2024-2032) ($MN)
42 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Formulation and Compounding (2024-2032) ($MN)
43 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Quality Control & Regulatory Compliance (2024-2032) ($MN)
44 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Logistics & Inventory Management (2024-2032) ($MN)
45 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By End User (2024-2032) ($MN)
46 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Pharmaceutical Manufacturing Companies (2024-2032) ($MN)
47 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
48 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs/CMOs) (2024-2032) ($MN)
49 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)
50 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging & Equipment Manufacturers (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
